| Thao Nguyen N Tran, MD | |
|
2000 Pepperell Pkwy, Opelika, AL 36801-5452 | |
| (334) 528-6610 | |
| Not Available |
| Full Name | Thao Nguyen N Tran |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 11 Years |
| Location | 2000 Pepperell Pkwy, Opelika, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821432402 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MD.33886 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| East Alabama Medical Center And Snf | Opelika, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The East Alabama Health Care Authority | 3072403237 | 81 |
News Archive
Further analysis of a Phase II study of therapeutic HIV vaccine candidate Vacc-4x revealed a potential biomarker associated with participants who experienced a more profound viral load reduction after receiving the vaccine.
Boise State University researchers have created anti-cancer drugs that are effective at killing 58 of the 60 types of tumors found in the National Cancer Institutes NCI-60 panel of cancer cells, which affect nine organ systems in the human body.
Athletes who take part in competitive sport should be screened for potentially fatal heart problems before they compete, according to a study published on BMJ.com.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the enrollment of the first two patients in TRYTON-LM, a prospective, single-arm study evaluating the feasibility of the Tryton stent in conjunction with Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System to treat stable patients with complex de novo bifurcation lesions involving the left main coronary artery.
› Verified 8 days ago
| Entity Name | Southview Medical Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801860333 PECOS PAC ID: 8729979794 Enrollment ID: O20040322000490 |
News Archive
Further analysis of a Phase II study of therapeutic HIV vaccine candidate Vacc-4x revealed a potential biomarker associated with participants who experienced a more profound viral load reduction after receiving the vaccine.
Boise State University researchers have created anti-cancer drugs that are effective at killing 58 of the 60 types of tumors found in the National Cancer Institutes NCI-60 panel of cancer cells, which affect nine organ systems in the human body.
Athletes who take part in competitive sport should be screened for potentially fatal heart problems before they compete, according to a study published on BMJ.com.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the enrollment of the first two patients in TRYTON-LM, a prospective, single-arm study evaluating the feasibility of the Tryton stent in conjunction with Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System to treat stable patients with complex de novo bifurcation lesions involving the left main coronary artery.
› Verified 8 days ago
| Entity Name | The East Alabama Health Care Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073685483 PECOS PAC ID: 3072403237 Enrollment ID: O20040824001092 |
News Archive
Further analysis of a Phase II study of therapeutic HIV vaccine candidate Vacc-4x revealed a potential biomarker associated with participants who experienced a more profound viral load reduction after receiving the vaccine.
Boise State University researchers have created anti-cancer drugs that are effective at killing 58 of the 60 types of tumors found in the National Cancer Institutes NCI-60 panel of cancer cells, which affect nine organ systems in the human body.
Athletes who take part in competitive sport should be screened for potentially fatal heart problems before they compete, according to a study published on BMJ.com.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the enrollment of the first two patients in TRYTON-LM, a prospective, single-arm study evaluating the feasibility of the Tryton stent in conjunction with Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System to treat stable patients with complex de novo bifurcation lesions involving the left main coronary artery.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thao Nguyen N Tran, MD 2000 Pepperell Pkwy, Opelika, AL 36801-5452 Ph: (334) 528-6610 | Thao Nguyen N Tran, MD 2000 Pepperell Pkwy, Opelika, AL 36801-5452 Ph: (334) 528-6610 |
News Archive
Further analysis of a Phase II study of therapeutic HIV vaccine candidate Vacc-4x revealed a potential biomarker associated with participants who experienced a more profound viral load reduction after receiving the vaccine.
Boise State University researchers have created anti-cancer drugs that are effective at killing 58 of the 60 types of tumors found in the National Cancer Institutes NCI-60 panel of cancer cells, which affect nine organ systems in the human body.
Athletes who take part in competitive sport should be screened for potentially fatal heart problems before they compete, according to a study published on BMJ.com.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the enrollment of the first two patients in TRYTON-LM, a prospective, single-arm study evaluating the feasibility of the Tryton stent in conjunction with Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System to treat stable patients with complex de novo bifurcation lesions involving the left main coronary artery.
› Verified 8 days ago
Amanda Elizabeth Austin, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 121 N 20th St Ste 6, Opelika, AL 36801 Phone: 334-705-3322 | |
Charles J Diskin, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2609 Village Professional Dr, Suite 3, Opelika, AL 36801 Phone: 334-749-6523 Fax: 334-742-0242 | |
Dr. Kevin P Ryan, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2601 Village Professional Dr N, Opelika, AL 36801 Phone: 334-528-5400 Fax: 334-528-5421 | |
Thomas Jefferson Stokes Jr., MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2609 Village Professional Dr, Suite 3, Opelika, AL 36801 Phone: 334-749-6523 Fax: 334-742-0242 | |
Dr. George Gregory Gilbert, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 121 N 20th St, #6, Opelika, AL 36801 Phone: 334-949-3385 Fax: 334-742-9243 | |
Dr. William P Mcgehee, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 121 N 20th St, #6, Opelika, AL 36801 Phone: 334-749-3385 Fax: 334-749-3385 | |
Joseph Rogers Downs Iii, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 121 N 20th St Ste 20b, Opelika, AL 36801 Phone: 334-321-3700 Fax: 334-887-7475 |